NBIX
Price
$132.54
Change
-$0.69 (-0.52%)
Updated
Apr 18, 6:59 PM EST
13 days until earnings call
OGI
Price
$1.87
Change
+$0.04 (+2.19%)
Updated
Apr 18, 6:59 PM EST
Ad is loading...

Compare predictions NBIX vs OGI

Header iconNBIX vs OGI Comparison
Open Charts NBIX vs OGIBanner chart's image
Neurocrine Biosciences
Price$132.54
Change-$0.69 (-0.52%)
Volume$253.36K
CapitalizationN/A
Organigram Holdings
Price$1.87
Change+$0.04 (+2.19%)
Volume$602.35K
CapitalizationN/A
View a ticker or compare two or three
NBIX vs OGI Comparison Chart

Loading...

NBIXDaily Signal changed days agoGain/Loss if shorted
 
Show more...
OGIDaily Signal changed days agoGain/Loss if shorted
 
Show more...
VS
NBIX vs. OGI commentary
Apr 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NBIX is a StrongSell and OGI is a StrongBuy.

COMPARISON
Comparison
Apr 18, 2024
Stock price -- (NBIX: $133.23 vs. OGI: $1.83)
Brand notoriety: NBIX and OGI are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: NBIX: 64% vs. OGI: 91%
Market capitalization -- NBIX: $13.72B vs. OGI: $200.85M
NBIX [@Pharmaceuticals: Other] is valued at $13.72B. OGI’s [@Pharmaceuticals: Other] market capitalization is $200.85M. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $2.8B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

NBIX’s FA Score shows that 0 FA rating(s) are green whileOGI’s FA Score has 0 green FA rating(s).

  • NBIX’s FA Score: 0 green, 5 red.
  • OGI’s FA Score: 0 green, 5 red.
According to our system of comparison, NBIX is a better buy in the long-term than OGI.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

NBIX’s TA Score shows that 5 TA indicator(s) are bullish while OGI’s TA Score has 3 bullish TA indicator(s).

  • NBIX’s TA Score: 5 bullish, 5 bearish.
  • OGI’s TA Score: 3 bullish, 7 bearish.
According to our system of comparison, NBIX is a better buy in the short-term than OGI.

Price Growth

NBIX (@Pharmaceuticals: Other) experienced а -3.52% price change this week, while OGI (@Pharmaceuticals: Other) price change was -11.59% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -3.24%. For the same industry, the average monthly price growth was +35.27%, and the average quarterly price growth was +18895.00%.

Reported Earning Dates

NBIX is expected to report earnings on Jul 30, 2024.

OGI is expected to report earnings on Nov 27, 2023.

Industries' Descriptions

@Pharmaceuticals: Other (-3.24% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
A.I.dvisor published
a Summary for NBIX with price predictions.
OPEN
A.I.dvisor published
a Summary for OGI with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
NBIX($13.7B) has a higher market cap than OGI($201M). OGI YTD gains are higher at: 39.695 vs. NBIX (1.116). NBIX has higher annual earnings (EBITDA): 358M vs. OGI (-195.74M). NBIX has more cash in the bank: 1.03B vs. OGI (42.3M). OGI has less debt than NBIX: OGI (136K) vs NBIX (428M). NBIX has higher revenues than OGI: NBIX (1.89B) vs OGI (161M).
NBIXOGINBIX / OGI
Capitalization13.7B201M6,816%
EBITDA358M-195.74M-183%
Gain YTD1.11639.6953%
P/E Ratio57.20N/A-
Revenue1.89B161M1,172%
Total Cash1.03B42.3M2,440%
Total Debt428M136K314,706%
FUNDAMENTALS RATINGS
NBIX vs OGI: Fundamental Ratings
NBIX
OGI
OUTLOOK RATING
1..100
7758
VALUATION
overvalued / fair valued / undervalued
1..100
84
Overvalued
60
Fair valued
PROFIT vs RISK RATING
1..100
39100
SMR RATING
1..100
6497
PRICE GROWTH RATING
1..100
5047
P/E GROWTH RATING
1..100
7494
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

OGI's Valuation (60) in the null industry is in the same range as NBIX (84) in the Biotechnology industry. This means that OGI’s stock grew similarly to NBIX’s over the last 12 months.

NBIX's Profit vs Risk Rating (39) in the Biotechnology industry is somewhat better than the same rating for OGI (100) in the null industry. This means that NBIX’s stock grew somewhat faster than OGI’s over the last 12 months.

NBIX's SMR Rating (64) in the Biotechnology industry is somewhat better than the same rating for OGI (97) in the null industry. This means that NBIX’s stock grew somewhat faster than OGI’s over the last 12 months.

OGI's Price Growth Rating (47) in the null industry is in the same range as NBIX (50) in the Biotechnology industry. This means that OGI’s stock grew similarly to NBIX’s over the last 12 months.

NBIX's P/E Growth Rating (74) in the Biotechnology industry is in the same range as OGI (94) in the null industry. This means that NBIX’s stock grew similarly to OGI’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
NBIXOGI
RSI
ODDS (%)
Bullish Trend 2 days ago
69%
Bearish Trend 2 days ago
88%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
72%
Bullish Trend 2 days ago
87%
Momentum
ODDS (%)
Bearish Trend 2 days ago
66%
Bearish Trend 2 days ago
85%
MACD
ODDS (%)
Bearish Trend 2 days ago
67%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
62%
Bearish Trend 2 days ago
87%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
65%
Bearish Trend 2 days ago
89%
Advances
ODDS (%)
Bullish Trend 2 days ago
72%
Bullish Trend 28 days ago
82%
Declines
ODDS (%)
Bearish Trend 4 days ago
62%
Bearish Trend 4 days ago
88%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
69%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bullish Trend 2 days ago
65%
Bullish Trend 2 days ago
87%
View a ticker or compare two or three
Ad is loading...
NBIXDaily Signal changed days agoGain/Loss if shorted
 
Show more...
OGIDaily Signal changed days agoGain/Loss if shorted
 
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
XPEV7.420.27
+3.78%
XPeng
BAND17.160.04
+0.23%
Bandwidth
KAR17.14-0.03
-0.17%
OPENLANE
LDTC2.16-0.06
-2.70%
LeddarTech Holdings
SXTC1.18-0.44
-27.16%
China SXT Pharmaceuticals

NBIX and

Correlation & Price change

A.I.dvisor tells us that NBIX and ITCI have been poorly correlated (+33% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that NBIX and ITCI's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NBIX
1D Price
Change %
NBIX100%
+0.18%
ITCI - NBIX
33%
Poorly correlated
-3.95%
DCPH - NBIX
27%
Poorly correlated
-0.81%
ACET - NBIX
25%
Poorly correlated
+3.65%
PCRX - NBIX
25%
Poorly correlated
-0.37%
SUPN - NBIX
24%
Poorly correlated
-1.46%
More

OGI and

Correlation & Price change

A.I.dvisor indicates that over the last year, OGI has been closely correlated with SNDL. These tickers have moved in lockstep 67% of the time. This A.I.-generated data suggests there is a high statistical probability that if OGI jumps, then SNDL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To OGI
1D Price
Change %
OGI100%
-2.66%
SNDL - OGI
67%
Closely correlated
-7.58%
CRON - OGI
57%
Loosely correlated
-0.82%
TLRY - OGI
51%
Loosely correlated
-6.01%
ACB - OGI
49%
Loosely correlated
-1.86%
CGC - OGI
48%
Loosely correlated
-3.13%
More